BRISTOL LABORATORIES LIMITED
Get an alert when BRISTOL LABORATORIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2025-12-31
Overdue
Confirmation statement due
2026-10-22 (in 5mo)
Last made up 2025-10-08
Watchouts
Cash
£516K
+14.7% vs 2023
Net assets
£29M
+5% vs 2023
Employees
531
+11.3% vs 2023
Profit before tax
£900K
-83.6% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Annual accounts overdue
Due 2025-12-31.
Net assets
5-year trend · vs Health Care median
Accounts
5-year trend · latest reflected 2024-03-31
| Metric | Trend | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | £70,023,117 | £66,782,846 | |
| Operating profit | — | — | — | £6,216,638 | £1,829,251 | |
| Profit before tax | — | — | — | £5,478,027 | £900,205 | |
| Net profit | — | — | — | £5,970,621 | £860,542 | |
| Cash | — | — | — | £450,003 | £515,934 | |
| Total assets less current liabilities | — | — | — | £30,836,602 | £30,840,948 | |
| Net assets | — | — | — | £27,697,738 | £29,071,355 | |
| Equity | — | — | — | £27,697,738 | £29,071,355 | |
| Average employees | — | — | — | 477 | 531 | |
| Wages | — | — | — | £16,476,771 | £17,759,879 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|---|---|---|
| Operating margin | — | — | — | 8.9% | 2.7% | |
| Net margin | — | — | — | 8.5% | 1.3% | |
| Return on capital employed | — | — | — | 20.2% | 5.9% | |
| Current ratio | — | — | — | 1.11x | 1.13x | |
| Interest cover | — | — | — | 8.42x | 1.96x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- King & King Chartered Accountants & Statutory Auditors
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors are of the opinion that the company has adequate resources to continue in operational existence for the foreseeable future on the understanding that the company has the on-going support from its bankers who are providing facilities to the company and sales financing to manage liquidity. Thus, the directors have adopted the going concern basis of accounting in preparing the financial statements.”
Group structure
- BRISTOL LABORATORIES LIMITED · parent
- Brilpharma Private Limited 100%
- Brilpharma S.L. 70%
Significant events
- “On 10 June 2024, Bristol Laboratories Ltd partially divested its investment in Brillpharma S.L. by disposing of a 29% equity stake for £6.7m, reducing its controlling interest from 70% to 49%, which would result in a reclassification from a subsidiary to an associate.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| NAIR KODUPURATH, Sreekumar, Mr. | Secretary | 2014-04-02 | — | — |
| RAMACHANDRAN, Priti | Director | 2016-11-01 | May 1982 | British |
| RAMACHANDRAN, Thembalath | Director | 2008-11-01 | Nov 1949 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| NAIR KODUPURATH, Sreekumar | Secretary | 2006-04-27 | 2014-04-02 |
| FIRST SECRETARIES LIMITED | Corporate Nominee Secretary | 1997-06-27 | 2006-06-07 |
| KODUPURATH, Sreekumar Nair, Mr. | Director | 2014-04-02 | 2014-04-02 |
| NAIR KODUPURATH, Sreekumar | Director | 2006-04-27 | 2014-04-02 |
| PASHINE, Sanjay Shrikishan | Director | 2017-01-09 | 2021-12-31 |
| PUTHENVILAYIL MATHAIKUTTY, Raju | Director | 1997-06-27 | 2021-02-14 |
| FIRST DIRECTORS LIMITED | Corporate Nominee Director | 1997-06-27 | 1997-06-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bristol Laboratories Group Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 146 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-07 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2026-03-19 | CH01 | officers | Change person director company with change date | |
| 2026-01-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-17 | AA | accounts | Accounts with accounts type full | |
| 2025-02-24 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-02-24 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-02-19 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-02-19 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-10-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-14 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-06-24 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-06-24 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-12-15 | MR05 | mortgage | Mortgage charge part both with charge number | |
| 2023-10-18 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-07-25 | AA | accounts | Accounts with accounts type full | |
| 2023-07-25 | AA | accounts | Accounts with accounts type full | |
| 2023-05-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-05-04 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-06-06 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-05-26 | MR04 | mortgage | Mortgage satisfy charge full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-03-31 vs 2023-03-31
-
Turnover
-4.6%
£70,023,117 £66,782,846
-
Cash
+14.7%
£450,003 £515,934
-
Net assets
+5%
£27,697,738 £29,071,355
-
Employees
+11.3%
477 531
-
Operating profit
-70.6%
£6,216,638 £1,829,251
-
Profit before tax
-83.6%
£5,478,027 £900,205
-
Wages
+7.8%
£16,476,771 £17,759,879
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers